Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.

NCT03976882 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Thrombocytopenia

Interventions

DRUG: Hetrombopag
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.